The parkin ubiquitin proteasomal system pathway (WP2359) and Alzheimer’s disease and miRNA effects (WP2059) reveal potential changes in neurobiological and metabolic processes in response to hormonal treatment. This evidence concerns the gene PRKN and Alzheimer disease.